ARCHIVES

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

This article is from The Cancer Letter archive.

Vol. 24 No. 14 | April 10, 1998

Download PDF Visit The Full Archive

Related Articles

Obituaries: Paul Carbone; John Eisenberg; Paul Grotzinger

March 15, 2002

NCI Advisors Approve New $5 Million Program For Reagent Contracts.

July 10, 2009

In Brief: Baylor Campus to Build Joint Cancer Center

January 17, 2014

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

September 26, 2003

Working Group Proposes “Equitable” Schema For Determining Cancer Center Core Grants

July 3, 2013

Tell NCI About science, Not Funding Mechanisms, Broder Says to Society

January 21, 1994